Average Co-Inventor Count = 12.64
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (10 from 1,829 patents)
2. Merck Sharp + Dohme Corp. (6 from 2,405 patents)
3. Dendreon Corporation (1 from 53 patents)
4. Merck Gmbh (1 from 17 patents)
17 patents:
1. 9540377 - 2,6,7,8 substituted purines as HDM2 inhibitors
2. 9156872 - 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
3. 9150603 - 2'-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases
4. 9062071 - Substituted piperidines as HDM2 inhibitors
5. 8987274 - Macrocycles that increase p53 activity and the uses thereof
6. 8859776 - Substituted piperidines that increase p53 activity and the uses thereof
7. 8067379 - Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
8. 7884107 - Substituted piperidines that increase P53 activity and the uses thereof
9. 7759499 - Compounds as inhibitors of hepatitis C virus NS3 serine protease
10. 7718691 - Compounds as inhibitors of hepatitis C virus NS3 serine protease
11. 7619094 - Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
12. 7423058 - Inhibitors of hepatitis C virus NS3 protease
13. 7244721 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
14. 7205330 - Inhibitors of hepatitis C virus NS3 protease
15. 7192957 - Compounds as inhibitors of hepatitis C virus NS3 serine protease